Human embryonic stem cells: emerging technologies and practical applications

Current Opinion in Genetics and Development

Volumn 18, Issue 4, 2008, Pages 324-329

  Fenno, Lief E ^a   Ptaszek, Leon M ^a,b   Cowan, Chad A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; DNA MODIFICATION; EMBRYONIC STEM CELL; HUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW;

BIOMEDICAL TECHNOLOGY; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYONIC STEM CELLS; HUMANS; MODELS, BIOLOGICAL;

EID: 53649094427     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2008.06.004     Document Type: Review

References (39)

1. Thomson J., Itskovitz-Eldor J., Shapiro S., Waknitz M., Swiergiel J., Marshall V., and Jones J. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
2. Vogel G. A knockout award in medicine. Science 318 (2007) 178-179
3. Evans M., and Kaufman M. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
4. Martin G. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. PNAS 78 (1981) 7634-7638
5. Cowan C., Klimanskaya I., McMahon J., Atienza J., Witmyer J., Zucker J., Wang S., Morton C., McMahon A., Powers D., et al. Derivation of embryonic stem-cell lines from human blastocysts. NEJM 350 (2004) 1353-1356
6. Akutsu H., Cowan C., and Melton D. Human embryonic stem cells. Methods Enzymol 418 (2006) 78-92
7. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., Stadtfeld M., Yachechko R., Tchieu J., Jaenisch R., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1 (2007) 55-70
8. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676. Identification of the factors is sufficient for reprogramming terminally differentiated somatic cells into an ESC-like pluripotent state.
9. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872. Adaptation of mouse-based reprogramming protocol to the human system.
10. Okita K., Ichisaka T., and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448 (2007) 313-317
11. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B., and Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318-324
12. Park I., Zhao R., West J., Yabuuchi A., Huo H., Ince T., Lerou P., Lensch M., and Daley G. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 145 (2008) 141-146
13. Yu J., Vodyanik M., Smuga-Otto K., Antosiewicz-Bourget J., Frane J., Tian S., Nie J., Jonsdottir G., Ruotti V., Stewart R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 319 (2007) 1917-1920
14. Kim J., Chu J., Shen X., Wang J., and Orkin S. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132 (2008) 1049-1061
15. Stadtfeld M., Maherali N., Breault D., and Hochedlinger K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2 (2008) 230-240
16. Brambrink T., Foreman R., Welstead G.G., Lengner C., Wernig M., Suh H., and Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2 (2008) 151-159
17. Hanna J., Markoulaki S., Schorderet P., Carey B., Beard C., Wernig M., Creyghton M., Steine E., Cassady J., Foreman R., et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133 (2008) 250-264
18. Nakagawa M., Koyanagi M., Tanabe K., Kazutoshi T., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N., and Yamanaka S. Generation of induced pluripotent stem cells without myc from mouse and human fibroblasts. Nat Biotechnol 26 (2007) 101-106
19. Initiative I.S.C., Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P., Beighton G., Bello P., Benvenisty N., Berry L., et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25 (2007) 803-816
20. Osafune K., Caron L., Borowiak M., Martinez R., Fitz-Gerald C., Sato Y., Cowan C., Chien K., and Melton D. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 26 (2008) 313-315. Identification of differences in differentiation proclivity between human ESC lines.
21. Monkhorst K., Jonkers I., Rentmeester E., Grosveld F., and Gribnau J. X inactivation counting and choice is a stochastic process: evidence for involvement of an X-linked activator. Cell 132 (2008) 410-421
22. Silva S., Rowntree R., Mekhoubad S., and Lee J. X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc Natl Acad Sci U S A 105 (2008) 4820-4825
23. Shen Y., Matsuno Y., Fouse S., Rao N., Root S., Xu R., Pellegrini M., Riggs A., and Fan G. Inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc Natl Acad Sci U S A 105 (2008) 4709-4714
24. Hall L, Byron M, Butler J, Becker K, Nelson A, Amit M, Itskovitz-Eldor J, Stein J, Stein G, Ware C et al.: X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. J Cell Physiol 2008, Epub March 13.
25. Ptaszek L., and Cowan C. New tools for genome modification in human embryonic stem cells. Cell Stem Cell 1 (2007) 600-602
26. Thyagarajan B, Liu Y, Shin S, Lakshmipathy U, Scheyhing K, Xue H, Ellerström C, Strehl R, Hyllner J, Rao M et al.: Creation of engineered human embryonic stem cell lines using phiC31 integrase. Stem Cells 2007, Epub October 25, 2007.
27. Irion S., Luche H., Gadue P., Fehling H., Kennedy M., and Keller G. Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat Biotechnol 25 (2007) 1477-1482
28. Liew C., Draper J., Walsh J., Moore H., and Andrews P. Transient and stable transgene expression in human embryonic stem cells. Stem Cells 25 (2007) 1521-1528
29. Chuang C., Sung L., Hwang S., Lo W., Chen H., and Hu Y. Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering. Gene Ther 14 (2007) 1417-1424
30. Koyanagi M., Takahashi J., Arakawa Y., Doi D., Fukuda H., Hayashi H., Narumiya S., and Hashimoto N. Inhibition of the Rho/ROCK pathway reduces apoptosis during transplantation of embryonic stem cell-derived neural precursors. J Neurosci Res 86 (2008) 270-280
31. Emre N., Coleman R., and Ding S. A chemical approach to stem cell biology. Curr Opin Chem Biol 11 (2007) 252-258
32. Bendall S., Stewart M., Menendez P., George D., Vijayaragavan K., Werbowetski-Ogilvie T., Ramos-Mejia V., Rouleau A., Yang J., Bossé M., et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448 (2007) 1015-1021
33. Wang L., Schulz T., Sherrer E., Dauphin D., Shin S., Nelson A., Ware C., Zhan M., Song C., Chen X., et al. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 110 (2007) 4111-4119
34. Ivey K., Muth A., Arnold J., King F., Yeh R., Fish J., Hsiao E., Schwartz R., Conklin B., Bernstein H., et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2 (2008) 219-229
35. Wang Y., Medvid R., Melton C., Jaenisch R., and Blelloch R. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Nat Genet 39 (2007) 380-385
36. Gropp M., Itsykson P., Singer O., Ben-Hur T., Reinhartz E., Galun E., and Reubinoff B.E. Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther 7 (2003) 281-287
37. Lombardo A., Genovese P., Beausejour C., Colleoni S., Lee Y., Kim K., Ando D., Urnov F., Galli C., Gregory P., et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25 (2007) 1298-1306
38. Zeng J., Du J., Zhao Y., Palanisamy N., and Wang S. Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 25 (2007) 1055-1061
39. Zwaka T.P., and Thomson J.A. Homologous recombination in human embryonic stem cells. Nat Biotechnol 21 (2003) 319-321